Mabion S.A.
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
MAB | WAR
Overview
Corporate Details
- ISIN(s):
- PLMBION00016 (+1 more)
- LEI:
- 259400KG5JVQPPZL6X53
- Country:
- Poland
- Address:
- Konstantynów Łódzki GEN. MARIANA LANGIEWICZA 60, 95-050 Konstantynów Łódzki
- Website:
- https://www.mabion.eu/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mabion S.A. is a biopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing end-to-end services to pharmaceutical and biotech companies globally. The company specializes in the development, analytics, and manufacturing of complex biologic drugs. Mabion leverages advanced statistical methodologies, such as Design of Experiments (DoE), to optimize bioprocesses, enhance product quality, and ensure regulatory compliance. This data-driven approach supports accelerated development timelines and efficient, robust manufacturing for its partners, demonstrated through its involvement in large-scale production projects for biologics and vaccine components.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-08 15:16 |
Audit Report / Information
Informacja dotycząca stanowiska Zarządu i opinii Rady Nadzorczej Mabion S.A. od…
|
Polish | 264.8 KB | ||
| 2025-10-08 15:16 |
Interim Report
Raport Biegłego Rewidenta
|
Polish | 497.9 KB | ||
| 2025-10-08 15:16 |
Interim Report
Oświadczenie Zarządu w sprawie rzetelności sporządzenia sprawozdania finansowego
|
Polish | 228.5 KB | ||
| 2025-10-08 15:16 |
Management Discussion and Analysis
Mabion_Sprawozdanie Zarządu_1H2025
|
Polish | 3.2 MB | ||
| 2025-10-08 15:16 |
Interim Report
Mabion MSSF_1H2025
|
Polish | 3.4 MB | ||
| 2025-10-08 15:16 |
Audit Report / Information
Stanowisko Zarządu i opinia Rady Nadzorczej Mabion S.A. odnoszące się do odmowy…
|
Polish | 368.1 KB | ||
| 2025-10-08 14:27 |
Audit Report / Information
Stanowisko Zarządu i opinia Rady Nadzorczej Mabion S.A. odnoszące się do odmowy…
|
Polish | 368.1 KB | ||
| 2025-10-08 14:27 |
Audit Report / Information
Uzupełnienie raportu okresowego Spółki za I półrocze 2025 roku - Content (EN)
|
English | 1.0 KB | ||
| 2025-10-08 14:27 |
Report Publication Announcement
Uzupełnienie raportu okresowego Spółki za I półrocze 2025 roku - Content (PL)
|
Polish | 784 bytes | ||
| 2025-10-01 21:37 |
Audit Report / Information
Informacja dotycząca stanowiska Zarządu i opinii Rady Nadzorczej Mabion S.A. od…
|
Polish | 264.8 KB | ||
| 2025-10-01 21:37 |
Interim Report
Raport Biegłego Rewidenta
|
Polish | 497.9 KB | ||
| 2025-10-01 21:37 |
Interim Report
Oświadczenie Zarządu w sprawie rzetelności sporządzenia sprawozdania finansowego
|
Polish | 228.5 KB | ||
| 2025-10-01 21:37 |
Management Discussion and Analysis
Mabion_Sprawozdanie Zarządu_1H2025
|
Polish | 3.2 MB | ||
| 2025-10-01 21:37 |
Interim Report
Mabion MSSF_1H2025
|
Polish | 3.4 MB | ||
| 2025-09-29 16:25 |
Capital/Financing Update
Otrzymanie z Twiti Investments Ltd. Term Sheet w sprawie warunków udzielenia Sp…
|
English | 2.2 KB |
Automate Your Workflow. Get a real-time feed of all Mabion S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Mabion S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
